Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LAB SCIENCE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.3% 1.3%   Bankruptcy risk   6.2% 4.8% 2.1% 1.2% 2.9% 3.2% 11.3% 11.0%   Credit score (0-100)   39 46 68 82 58 55 22 22   Credit rating   BBB BBB A A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 1.2 154.6 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   62.2 224 8,775 3,245 526 467 0.0 0.0   EBITDA   59.9 224 8,775 2,995 174 457 0.0 0.0   EBIT   59.9 224 8,701 2,978 157 439 0.0 0.0   Pre-tax profit (PTP)   57.6 218.9 8,676.2 2,931.5 100.8 452.6 0.0 0.0   Net earnings   44.8 170.3 6,765.5 2,284.3 78.3 354.1 0.0 0.0   Pre-tax profit without non-rec. items   57.6 219 8,676 2,931 101 453 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 73.0 105 88.0 70.9 0.0 0.0   Shareholders equity total   257 428 7,123 2,807 2,886 955 875 875   Interest-bearing liabilities   224 120 987 3,248 672 5,545 0.0 0.0   Balance sheet total (assets)   555 691 14,522 6,552 6,627 7,386 875 875   Net Debt   -211 -290 -4,665 1,768 -704 4,099 -875 -875     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   62.2 224 8,775 3,245 526 467 0.0 0.0   Gross profit growth   -56.9% 259.5% 3,821.9% -63.0% -83.8% -11.2% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   555 691 14,522 6,552 6,627 7,386 875 875   Balance sheet change%   -1.5% 24.5% 2,002.4% -54.9% 1.1% 11.4% -88.1% 0.0%   Added value   59.9 223.7 8,775.0 2,994.7 174.4 456.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 -1 15 -34 -34 -71 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   96.3% 100.0% 99.2% 91.8% 29.9% 94.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.7% 35.9% 114.4% 28.3% 2.4% 6.5% 0.0% 0.0%   ROI %   15.1% 43.5% 201.0% 42.0% 3.3% 9.0% 0.0% 0.0%   ROE %   19.1% 49.7% 179.2% 46.0% 2.7% 18.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   46.4% 61.9% 49.1% 42.8% 43.5% 12.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -351.9% -129.7% -53.2% 59.0% -403.5% 897.7% 0.0% 0.0%   Gearing %   86.9% 28.2% 13.9% 115.7% 23.3% 580.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.4% 2.8% 4.5% 2.2% 2.9% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 2.3 1.9 1.7 1.7 1.1 0.0 0.0   Current Ratio   1.9 2.6 2.0 1.7 1.7 1.1 0.0 0.0   Cash and cash equivalent   434.6 410.6 5,651.9 1,480.2 1,375.7 1,446.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   257.2 427.6 7,050.1 2,702.2 2,797.6 884.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0